EXPERIENCE AXELA EFFICIENCY: ultrasensitive & multiplex

About Axela

Our Mission

About Axela

A trusted New Jersey CRO, specializing in discovery biology, translational sciences, GLP compatible bioanalysis and CLIA testing to ACCELERATE the development of novel therapeutics and diagnostics.

Our History

Our Mission

About Axela

Merged from PicoImmune, NanoBiotec and Emerther USA, offering ultrasensitive, multiplex and reliable bioassays for real-time monitoring of protein and gene changes in minute samples.

Our Mission

Driving forward high-caliber innovations into therapeutics by maximizing insights from minute samples, delivering efficiency to our partner and benefit our patients today, rather tomorrow.

Focused Services & Solutions

Discovery Biology

GLP Bioanalysis, CLIA test

Translational Sciences

Discovery Biology & In Vitro Pharmacology Target Identification &
High-throughput & High-Content Screening
Cell-based & Cell-free Assays
Cancer & Immune Cell Proﬁling
Tumor-immune 3D Culture and Organoids
In Vitro, Ex Vivo 3D Culture Models

Translational Sciences

GLP Bioanalysis, CLIA test

Translational Sciences

MOA Studies
Combination Strategy
Biomarker Discovery/Validation
Biomarker Quantitation (PD)
IF, mIF, IHC, mIHC
FISH & RNAscope
Spatial Genomics
Spatial Proteomics

GLP Bioanalysis, CLIA test

PK Bioanalysis
Immunogenicity
ADA Assessment
Central Lab Management
In Vitro Toxicity Studies under OECD & ICH
Laboratory Developed Tests (LDT)
Companion Diagnostics (CDx)
Kit Production, Fulfillment & Distribution

State-of-arts Platforms

Support for Various Indications

GLP Bioanalysis, CLIA test

Ultrasensitive and Multiplex Immunoassays
High-dimensional Cytometry
Systematic Immuno-monitoring
IHC Auto-stainer and Digital Histology
Multiplex miRNA / mRNA Proﬁling
Real-Time Live Cell Imaging
Spatial Genomics and Proteomics
Gene and Protein Microarrays

Support for Various Modalities

Support for Various Indications

Small Molecules & Peptides
Nanobody, Antibodies & ADCs
PROTACs & Molecular Glues
Exosome, LNPs
Cell & Gene Therapies

Support for Various Indications

Cancers (Solid & Hematopoietic)
I&I, Autoimmune
Dermatology
Asthma, Allergy, Chronic Urticaria
Neurodegenerative Diseases
Metabolic Diseases
Other Diseases

Services for Preclinical and Clinical R&D Needs

EXPERIENCE AXELA EFFICIENCY

Our Vision

Axela Biosciences, Inc. offers highly sensitive, multiplex and reliable bioassay services for real-time monitoring of protein and gene changes in minute samples from cells, animals, and patients, thereby expediting the discovery and development of novel therapeutics.

Our Team

Our team possesses extensive expertise in drug discovery and unparalleled proficiency in bioanalytical, cytometric, genomic, and proteomic techniques. We harness the power of ultra-sensitive pico-scale and multiplex immunoassay as well as microarray technologies. Our employees have received training at prestigious institutions such as MIT, NIH, MSKCC, Rutgers, NYU, Duke and have accumulated decades of experience working for multinational biopharma companies including Novartis, Sanofi, Merck, BMS/Celgene, and Regeneron. We acquire and analyze data from multi-level experiments to assess drug efficacy while elucidating the underlying mechanisms of drugs and diseases.

Partnering

Axela Bio is a privately held contract research organization (CRO) committed to enhancing the efficiency of discovering innovative therapeutic drugs. We offer cost-effective services to biopharma and academic investigators, aiming to expedite the development of novel drugs and personalized medicine for cancer, autoimmune, and various other unmet medical conditions. Our strategic focus lies in establishing R&D partnerships with biotech, pharma, diagnostic companies, as well as academic institutions. Axela Bio welcomes proposals for R&D collaboration and strategic partnerships. For further information, please contact us at info@axelabio.com.

OUR SERVICES

Immunoassay: Highly Sensitive and Multiplex
Immunology & Immune Cell Functional Assays
Flow Cytometry
Phospho-Flow
Mass Cytometry
Preclinical Biology
Induced Proximity Drug-: PROTAC, Molecular Glues
Geno-, Hemato-, & Immuno-toxicity Testing
NanoString nCounter, Transcriptomics
NanoString GeoMx DSP, Spatial-Omics, multiplex IHC
Translational Development
QuantiGene & PCR Arrays
Protein arrays (Forward and Reverse Phase Protein Arrays)
O-link Proteomics
Biorepository
In Vitro DMPK
Animal Models for Cancer and Inflammation
Products: Human Immune Cells and Others

Our Platforms

We have established a state-of-the-art infrastructure equipped with cutting-edge technologies and advanced instruments. Our suite of sophisticated platforms enables highly sensitive bioanalysis and drug screening using minimal sample sizes, thereby allowing us to meet diverse assay performance requirements. Our dedicated scientists possess extensive hands-on experience and training in utilizing these technologies and instruments, diligently adhering to well-validated protocols for swift and accurate processing and analysis of samples.

Flow Cytometry (CytoFlex S; BD FACSymphony A3 )
NanoString nCounter and GeoMx DSP (digital spatial profiler)
FlexMAP3D, Luminex 200 (beads-based protein and gene array, 96- or 384-well format)
SIMOA (SIngle MOlecule Array)
Simple Western (Gel-free Capillary-based Automatic Western Blot)
Proteomic Microarray (Forward and Reverse Phase Protein Array, FPPA/RPPA)
Olink Q100 (Proximity Extension Assay, Olink Proteomics))
ABI QuantStudio Real-Time PCR
RTCA (Real Time Cell Analysis)
LiCor Odyssey Near-Infrared Imaging System
ELISA / ELISpot Reader
IncuCyte Live Cell Analysis System
EVOS FL Auto Cell Imaging System
Molecular Devices GenePix 4200AL Microarray Scanner
Spark® Multimode Microplate Reader
Integra ASSIST PLUS automated multichannel pipetting Robots
Miltenyi Biotec autoMACS® Pro Separator

WHY WORK WITH US?

Expertise in maximizing information from minute test samples is achieved by harnessing the power of ultrasensitive pico-scale and multiplex immunoassays.
Better data acquisition and richer information are obtained from a reduced number of samples, thereby minimizing the need for animal use.
The turnaround time is accelerated, resulting in higher quality data and more competitive prices.
Each project is meticulously designed according to its specific goals, ensuring customization and success.
Intellectual properties are carefully safeguarded while fostering long-term relationships with clients.
Confidence is instilled in every client, irrespective of their size or whether they belong to commercial or academic entities.
Greater flexibility for collaborations with academia and startups is provided.

FEEDBACK FROM CLIENTS

“...we very much appreciate your flexibility to work with us and allowed quick assessment of antibodies that might be useful for feasibility testing in… I also want to express our appreciation for your timely data communication, it was neat, clear, and transparent. Thank you for your partnership.”

--- BMS Principal Investigator, Cardiovascular Biology

“Working with Axela removes the guess work. I always know the status of my immune cell functional assay project because their team of scientists communicates regularly.”

---Senior Scientist, Gilead

Axela --A Science-driven CRO, Accelerating Life Sciences Forward

Axela --A Science-driven CRO, Accelerating Life Sciences Forward

EXPERIENCE AXELA EFFICIENCY: ultrasensitive & multiplex

About Axela

Our Mission

About Axela

Our History

Our Mission

About Axela

Our Mission

Our Mission

Our Mission

Focused Services & Solutions

Discovery Biology

GLP Bioanalysis, CLIA test

Translational Sciences

Translational Sciences

GLP Bioanalysis, CLIA test

Translational Sciences

GLP Bioanalysis, CLIA test

GLP Bioanalysis, CLIA test

GLP Bioanalysis, CLIA test

State-of-arts Platforms

Support for Various Indications

GLP Bioanalysis, CLIA test

Support for Various Modalities

Support for Various Indications

Support for Various Indications

Support for Various Indications

Support for Various Indications

Support for Various Indications

A Trustable Partner to Accelerate Innovation

Our Services

Our Technical Advantages

Services for Preclinical and Clinical R&D Needs

EXPERIENCE AXELA EFFICIENCY

OUR SERVICES

Our growing number of satisfied clients and partners

FEEDBACK FROM CLIENTS

We are working hard to connect your discovery to clinic, and scientists to patients.

Axela --A Science-driven CRO, Accelerating Life Sciences Forward

Axela --A Science-driven CRO, Accelerating Life Sciences Forward

EXPERIENCE AXELA EFFICIENCY: ultrasensitive & multiplex

About Axela

Our Mission

About Axela

Our History

Our Mission

About Axela

Our Mission

Our Mission

Our Mission

Focused Services & Solutions

Discovery Biology

GLP Bioanalysis, CLIA test

Translational Sciences

Translational Sciences

GLP Bioanalysis, CLIA test

Translational Sciences

GLP Bioanalysis, CLIA test

GLP Bioanalysis, CLIA test

GLP Bioanalysis, CLIA test

State-of-arts Platforms

Support for Various Indications

GLP Bioanalysis, CLIA test

Support for Various Modalities

Support for Various Indications

Support for Various Indications

Support for Various Indications

Support for Various Indications

Support for Various Indications

A Trustable Partner to Accelerate Innovation

Our Services

Our Technical Advantages

Services for Preclinical and Clinical R&D Needs

EXPERIENCE AXELA EFFICIENCY

OUR SERVICES

Our growing number of satisfied clients and partners

FEEDBACK FROM CLIENTS

We are working hard to connect your discovery to clinic, and scientists to patients.

This website uses cookies.